Editas Medicine, Inc. - Common Stock (EDIT)

CUSIP: 28106W103

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Equity / Common Stock
Shares outstanding
82,773,190
Total 13F shares
54,069,648
Share change
+5,874,731
Total reported value
$479,580,650
Put/Call ratio
75%
Price per share
$8.87
Number of holders
245
Value change
+$43,275,611
Number of buys
105
Number of sells
109

Security key

28106W103

Report period

Q4 2022

Institutions

245

Top holders

10

Top shareholders of EDIT - Editas Medicine, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BlackRock Finance, Inc.
13F
Company
8.4%
6,982,775
$85,469,000 30 Sep 2022
13F
VANGUARD GROUP INC
13F
Company
8.1%
6,725,340
$82,318,000 30 Sep 2022
13F
STATE STREET CORP
13F
Company
7.7%
6,348,781
$77,709,000 30 Sep 2022
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
2.3%
1,882,870
$23,046,000 30 Sep 2022
13F
PFM Health Sciences, LP
13F
Company
1.5%
1,279,054
$15,656,000 30 Sep 2022
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1.5%
1,256,520
$15,379,000 30 Sep 2022
13F
JPMORGAN CHASE & CO
13F
Company
1.4%
1,163,326
$14,239,000 30 Sep 2022
13F
GOLDMAN SACHS GROUP INC
13F
Company
1.3%
1,115,723
$13,657,000 30 Sep 2022
13F
Capital World Investors
13F
Company
1.3%
1,100,000
$13,464,000 30 Sep 2022
13F
TWO SIGMA ADVISERS, LP
13F
Company
1.3%
1,076,500
$13,176,000 30 Sep 2022
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
1.2%
1,007,055
$12,326,000 30 Sep 2022
13F
CREDIT SUISSE AG/
13F
Company
1.2%
1,000,378
$12,245,000 30 Sep 2022
13F
MORGAN STANLEY
13F
Company
1.1%
905,693
$11,086,000 30 Sep 2022
13F
CITADEL ADVISORS LLC
13F
Company
1.1%
894,871
$10,953,000 30 Sep 2022
13F
NORTHERN TRUST CORP
13F
Company
0.94%
775,068
$9,488,000 30 Sep 2022
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.79%
656,502
$8,035,000 30 Sep 2022
13F
Nuveen Asset Management, LLC
13F
Company
0.71%
583,747
$7,146,000 30 Sep 2022
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.6%
499,456
$6,114,000 30 Sep 2022
13F
CAPITAL FUND MANAGEMENT S.A.
13F
Company
0.6%
494,850
$6,056,964 30 Sep 2022
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.55%
458,795
$5,615,000 30 Sep 2022
13F
Rafferty Asset Management, LLC
13F
Company
0.53%
437,761
$5,358,000 30 Sep 2022
13F
CITIGROUP INC
13F
Company
0.52%
427,681
$5,235,000 30 Sep 2022
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.47%
390,792
$4,784,000 30 Sep 2022
13F
Cubist Systematic Strategies, LLC
13F
Company
0.46%
376,927
$4,614,000 30 Sep 2022
13F
NORGES BANK
13F
Company
0.44%
366,338
$4,483,977 30 Sep 2022
13F
Amova Asset Management Americas, Inc.
13F
Company
0.43%
355,836
$4,359,000 30 Sep 2022
13F
Sumitomo Mitsui Trust Group, Inc.
13F
Company
0.43%
355,836
$4,355,000 30 Sep 2022
13F
Mirae Asset Global Investments Co., Ltd.
13F
Company
0.43%
352,739
$4,318,000 30 Sep 2022
13F
Man Group plc
13F
Company
0.37%
309,653
$3,790,000 30 Sep 2022
13F
BARCLAYS PLC
13F
Company
0.36%
300,227
$3,675,000 30 Sep 2022
13F
STATE OF MICHIGAN RETIREMENT SYSTEM
13F
Company
0.33%
273,721
$3,350,000 30 Sep 2022
13F
Bank of New York Mellon Corp
13F
Company
0.31%
253,290
$3,100,000 30 Sep 2022
13F
Lombard Odier Asset Management (Switzerland) SA
13F
Company
0.29%
242,248
$2,965,000 30 Sep 2022
13F
Connor, Clark & Lunn Investment Management Ltd.
13F
Company
0.29%
240,244
$2,941,000 30 Sep 2022
13F
Edgestream Partners, L.P.
13F
Company
0.26%
214,803
$2,629,000 30 Sep 2022
13F
Schonfeld Strategic Advisors LLC
13F
Company
0.26%
213,302
$2,610,000 30 Sep 2022
13F
AMERIPRISE FINANCIAL INC
13F
Company
0.24%
200,534
$2,454,000 30 Sep 2022
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.23%
189,566
$2,321,000 30 Sep 2022
13F
BNP PARIBAS FINANCIAL MARKETS
13F
Company
0.23%
189,285
$2,316,848 30 Sep 2022
13F
PICTET ASSET MANAGEMENT SA
13F
Company
0.22%
182,186
$2,230,000 30 Sep 2022
13F
Jefferies Group LLC
13F
Company
0.21%
170,142
$2,082,538 30 Sep 2022
13F
D. E. Shaw & Co., Inc.
13F
Company
0.2%
165,621
$2,027,000 30 Sep 2022
13F
HRT FINANCIAL LP
13F
Company
0.2%
164,713
$2,016,000 30 Sep 2022
13F
Swiss National Bank
13F
Company
0.2%
161,700
$1,979,000 30 Sep 2022
13F
Graham Capital Management, L.P.
13F
Company
0.19%
158,186
$1,936,000 30 Sep 2022
13F
Qube Research & Technologies Ltd
13F
Company
0.18%
147,929
$1,811,000 30 Sep 2022
13F
SHELTON CAPITAL MANAGEMENT
13F
Company
0.18%
145,400
$1,780,000 30 Sep 2022
13F
ARK Investment Management LLC
13F
Company
0.18%
145,292
$1,778,000 30 Sep 2022
13F
Laurion Capital Management LP
13F
Company
0.17%
140,659
$1,722,000 30 Sep 2022
13F
STATE OF WISCONSIN INVESTMENT BOARD
13F
Company
0.15%
127,298
$1,558,000 30 Sep 2022
13F

Institutional Holders of Editas Medicine, Inc. - Common Stock (EDIT) as of Q4 2022

As of 31 Dec 2022, Editas Medicine, Inc. - Common Stock (EDIT) was held by 245 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 54,069,648 shares. The largest 10 holders included STATE STREET CORP, BlackRock Inc., VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, Woodline Partners LP, DIMENSIONAL FUND ADVISORS LP, PFM Health Sciences, LP, GEODE CAPITAL MANAGEMENT, LLC, JPMORGAN CHASE & CO, and Capital World Investors. This page lists 245 institutional shareholders reporting positions in this security for the Q4 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2022 vs Q3 2022 Across Filers

Q3 2022 holders
243
Q4 2022 holders
245
Holder diff
2
Investor Q3 2022 Shares Q4 2022 Shares Share Diff Share Chg % Q3 2022 Value $ Q4 2022 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .